94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Sa Feng1,2†
Linyan Liu1,2†
Yuelin Cheng1,2†
Mengmeng Zhou1,2
Haoqiang Zhu1,2
Xinyan Zhao1,2
Ziyu Chen1,2
Shunli Kan1,2
Xuanhao Fu1,2Wei Hu1,2
Rusen Zhu1,2*- 1Department of Spine Surgery, Tianjin Union Medical Center, Tianjin Medical University, Tianjin, China
- 2Tianjin Institute of Spinal Surgery, Tianjin Union Medical Center, Tianjin, China
by Feng S, Liu L, Cheng Y, Zhou M, Zhu H, Zhao X, Chen Z, Kan S, Fu X, Hu W and Zhu R (2024). Front. Pharmacol. 15:1434652. doi: 10.3389/fphar.2024.1434652
In the published article, there was an error in the Funding statement. Crucial funding information was inadvertently omitted. The missing funding details pertain to “Tianjin Municipal Health Commission’s Integrated Traditional Chinese Medicine and Western Medicine Project Key Project (2023057),” which played a significant role in supporting and facilitating the research presented in the article. The correct Funding statement appears below.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by Tianjin Union Medical Center (2022JZXK05, 2022JZXK02, 2023YJZD002, 2022JZXK06), Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-064B), Tianjin Municipal Health Commission’s Integrated Traditional Chinese Medicine and Western Medicine Project (2021125), Tianjin Municipal Health Commission’s Integrated Traditional Chinese Medicine and Western Medicine Project Key Project (2023057).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: spinal cord injury, icariin, reactive astrogliosis, YAP, PPM1B
Citation: Feng S, Liu L, Cheng Y, Zhou M, Zhu H, Zhao X, Chen Z, Kan S, Fu X, Hu W and Zhu R (2024) Corrigendum: Icariin promotes functional recovery in rats after spinal cord injury by inhibiting YAP and regulating PPM1B ubiquitination to inhibiting the activation of reactive astrocytes. Front. Pharmacol. 15:1523605. doi: 10.3389/fphar.2024.1523605
Received: 12 November 2024; Accepted: 12 November 2024;
Published: 28 November 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Feng, Liu, Cheng, Zhou, Zhu, Zhao, Chen, Kan, Fu, Hu and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Rusen Zhu, enJzc3BpbmVAMTYzLmNvbQ==
†These authors have contributed equally to this work and share first authorship